Wilfong Diane E. 4
4 · GILEAD SCIENCES, INC. · Filed Sep 11, 2025
Insider Transaction Report
Form 4
Wilfong Diane E
Interim Corp Controller & CAO
Transactions
- Exercise/Conversion
Restricted Stock Unit
2025-09-10−921→ 7,864 total→ Common Stock (921 underlying) - Exercise/Conversion
Common Stock
2025-09-10+921→ 46,597 total - Tax Payment
Common Stock
2025-09-10$115.25/sh−338$38,955→ 46,259 total
Footnotes (2)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.